Adhera Financial Statements From 2010 to 2026
| ATRX Stock | USD 0.0001 0.00 0.00% |
Check Adhera Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Adhera Therapeutics' main balance sheet or income statement drivers, such as , as well as many indicators such as . Adhera financial statements analysis is a perfect complement when working with Adhera Therapeutics Valuation or Volatility modules.
Adhera |
Adhera Therapeutics Company Number Of Shares Shorted Analysis
Adhera Therapeutics' Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
Current Adhera Therapeutics Number Of Shares Shorted | 2.05 K |
Most of Adhera Therapeutics' fundamental indicators, such as Number Of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Adhera Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
| Competition |
Based on the recorded statements, Adhera Therapeutics has 2.05 K of outstending shares currently sold short by investors. This is 99.94% lower than that of the Biotechnology sector and 99.96% lower than that of the Health Care industry. The number of shares shorted for all United States stocks is 99.96% higher than that of the company.
Adhera Therapeutics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Adhera Therapeutics's current stock value. Our valuation model uses many indicators to compare Adhera Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Adhera Therapeutics competition to find correlations between indicators driving Adhera Therapeutics's intrinsic value. More Info.Adhera Therapeutics is rated below average in return on asset category among its peers. It is rated third in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Adhera Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Adhera Therapeutics' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Adhera Therapeutics Financial Statements
Adhera Therapeutics investors use historical fundamental indicators, such as Adhera Therapeutics' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Adhera Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Adhera Therapeutics, Inc. focuses on the discovery and development of drugs. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana. Adhera Therapeutics is traded on OTC Exchange in the United States.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| JBL | Jabil Circuit | |
| MRK | Merck Company | |
| AMGN | Amgen Inc |
Additional Tools for Adhera Pink Sheet Analysis
When running Adhera Therapeutics' price analysis, check to measure Adhera Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adhera Therapeutics is operating at the current time. Most of Adhera Therapeutics' value examination focuses on studying past and present price action to predict the probability of Adhera Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adhera Therapeutics' price. Additionally, you may evaluate how the addition of Adhera Therapeutics to your portfolios can decrease your overall portfolio volatility.